Home >> Signaling Pathways >> Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Products for  Immunology/Inflammation

  1. Cat.No. 产品名称 Information
  2. GC18290 Chrysomycin A

    金黄霉素A

    An antibiotic with antitumor properties
  3. GC18274 Amiprofos-methyl

    甲基胺草磷,BAY-NTN 6867

    An herbicide
  4. GC18273 SB 202190 (hydrochloride) A potent and selective p38 MAP kinase inhibitor
  5. GC18271 Polmacoxib

    帕马考昔,CG100649

    An inhibitor of COX-2 and carbonic anhydrase
  6. GC18268 Cyclo(L-Trp-L-Trp)

    Cyclic dioxopiperazine-L-tryptophan-L-tryptophan

    A cyclic dipeptide
  7. GC18259 DETA NONOate

    Diethylamine NONOate; NOC-18

    A nitric oxide donor

  8. GC18241 Lysophosphatidylcholines

    L-溶血卵磷脂,Lyso-Lecithins (egg)

    A glycerophospholipid
  9. GC18235 1-O-Hexadecyl-sn-glycerol

    鲛肝醇,α-Chimyl Alcohol, (S)-(+)-Chimyl Alcohol

    An alkyl glyceryl ether
  10. GC18226 Ac-LEHD-AMC (trifluoroacetate salt)

    Ac-Leu-Glu-His-Asp-AMC, Caspase-9 Substrate

    A caspase-9 fluorogenic substrate
  11. GC18200 BI-605906 An IKKβ inhibitor
  12. GC18191 Elastatinal

    (2S)-2-[(4S)-2-氨基-1,4,5,6-四羟基4-嘧啶基]-N-[[[(1S)-1-羰基-3-甲基丁基]氨基]羰基]甘氨酰-N1-[(1S)-1-甲基-2-氧乙基-L-谷氨酸甲酰胺

    A potent inhibitor of pancreatic elastase
  13. GC18190 Lecanoric Acid

    紅粉苔酸

    An antioxidant
  14. GC18181 GW 405833

    1-(2,3-二氯苯甲酰基)-5-甲氧基-2-甲基-3-[2-(4-吗啉基)乙基]-1H-吲哚,L768242

    A selective CB2 partial agonist
  15. GC11302 Hinokitiol

    桧木醇; β-Thujaplicin

    A tropolone with diverse biological activities
  16. GC10520 Dextran sulfate sodium salt (M.W 200000)

    硫酸葡聚糖钠盐

    A sulfated polysaccharide

  17. GC10764 IT-901 An inhibitor of the NF-κB subunit c-Rel
  18. GC10634 MCC950 sodium

    N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐,CRID3 sodium salt

    MCC950 是一种有效的选择性小分子 NLRP3 抑制剂。
  19. GC15168 Urolithin A

    尿石素A

    A metabolite of ellagic acid with diverse biological activities

  20. GC13400 Ac-VDVAD-AFC

    N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-Trifluoromethylcoumarin Caspase-2 Substrate (Fluorogenic)

    A fluorogenic substrate for caspase-2
  21. GC13859 Z-DEVD-AFC

    Caspase-3 Fluorogenic Substrate IV

    A caspase-3 fluorogenic substrate
  22. GC12367 CM-272 An inhibitor of G9a, GLP, and DNA methyltransferases
  23. GC11745 S-(2-aminoethyl) Isothiourea (dihydrobromide)

    乙胺硫脲,Antiradon,NSC 22877

    A non-selective inhibitor of all NOS isoforms
  24. GC11323 α-Guanidinoglutaric Acid

    (S)-(-)-2-胍基戊二酸,GGA

    An inhibitor of nNOS
  25. GC14864 Gardiquimod

    4-氨基-2-[(乙基氨基)甲基]-ALPHA,ALPHA-二甲基-1H-咪唑并[4,5-C]喹啉-1-乙醇

    A selective agonist of human TLR7
  26. GC14627 1,4-PBIT (dihydrobromide) A potent inhibitor of iNOS and nNOS
  27. GC11173 1,3-PBIT (dihydrobromide)

    亚苯基-1,3-双(乙烷-2-异硫脲)二氢溴酸

    A potent inhibitor of iNOS
  28. GC10851 S-ethyl N-[4-(trifluoromethyl)phenyl] Isothiourea (hydrochloride)

    S-乙基-N-[4-(三氟甲基)苯基]异硫脲盐酸盐,EPIT

    A selective, competitive inhibitor of nNOS
  29. GC17084 2-Imino-4-methylpiperidine (acetate)

    2-亚氨基-4-甲基哌啶乙酸酯

    A potent, general NOS inhibitor
  30. GC13058 NK 252 A Nrf2 activator
  31. GC13214 S-methyl-L-Thiocitrulline (hydrochloride)

    methyl-TC (hydrochloride)

    A potent NOS inhibitor
  32. GC11163 L-NMMA (citrate)

    L-NG-monomethyl Arginine citrate

    A non-selective NOS inhibitor
  33. GC15360 Methyl-L-NIO (hydrochloride) A nitric oxide synthase inhibitor
  34. GC11817 PDM 2 A resveratrol-based aryl hydrocarbon receptor antagonist
  35. GC17237 NG,NG-dimethyl-L-Arginine (hydrochloride)

    不对称二甲基精氨酸二盐酸盐溶液,100PPM,ADMA

    An endogenous NOS inhibitor
  36. GC14847 Psoralidin

    补骨脂定

    A furanocoumarin with anti-cancer activity
  37. GC16200 L-Biopterin

    L-生物喋呤,L-erythro-Biopterin,NSC 339699

    An intermediate for tetrahydro-L-biopterin
  38. GC17632 Maslinic Acid

    山楂酸; Crategolic acid; 2α-Hydroxyoleanolic acid

    Maslinic Acid是一种五环三萜酸,广泛存在于橄榄和其他植物中。Maslinic Acid具有抗炎、抗氧化、抗肿瘤、降血糖和神经保护等多种生物活性。
  39. GC13429 Vanillic acid

    香草酸

    香草酸是一种存在于可食用植物和水果中的调味剂,也存在于当归中。
  40. GC15457 Pyridoxine

    吡哆醇; Pyridoxol

    A 4-methanol form of vitamin B6
  41. GC12928 Vinyl-L-NIO (hydrochloride) A potent, selective nNOS inhibitor
  42. GC14965 Ethyl-L-NIO (hydrochloride)

    L-N5-(1-Iminobutyl)ornithine hydrochloride

    A modestly selective NOS inhibitor
  43. GC14076 Propenyl-L-NIO (hydrochloride)

    ENIPO

    iNOS inhibitor
  44. GC12370 IKK-16 (hydrochloride)

    IKK Inhibitor VII

    A potent inhibitor of IKKs

  45. GC12537 ATB-337

    ACS 15,S-Diclofenac

    A hydrogen sulfide-releasing NSAID
  46. GC13386 ML351

    CID 664510

    ML351是一种选择性15-脂氧合酶-1(15-LOX-1;12/15-LOX)抑制剂,IC50为200nM。

  47. GC18042 Isoprinosine

    异丙肌苷,Inosine pranobex,NP 113,NPT 10381

    An immunomodulatory antiviral complex
  48. GC16245 ATB-343 A H2S-releasing NSAID
  49. GC13662 (±)-Lisofylline

    利索茶碱,BL 194,CT-1501R,LSF

    A potent inhibitor of phosphatidic acid generation
  50. GC12578 (R)-Lisofylline

    (−)-Lisofylline,(R)-LSF

    A potent anti-inflammatory agent
  51. GC11867 (S)-Lisofylline

    (+)-Lisofylline,(S)-LSF

    The inactive enantiomer of a potent anti-inflammatory

Items 3851 to 3900 of 4267 total

per page

Set Descending Direction